Edition:
United States

Exelixis Inc (EXEL.O)

EXEL.O on Nasdaq

23.11USD
21 Feb 2017
Change (% chg)

$-0.01 (-0.04%)
Prev Close
$23.12
Open
$23.28
Day's High
$23.49
Day's Low
$22.94
Volume
3,934,172
Avg. Vol
5,816,912
52-wk High
$23.49
52-wk Low
$3.55

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

Stelios Papadopoulos

67 1998 Independent Chairman of the Board, Co-Founder

Michael Morrissey

55 2010 President, Chief Executive Officer, Director

Christopher Senner

48 2015 Chief Financial Officer, Executive Vice President

Gisela Schwab

59 2016 President, Product Development and Medical Affairs and Chief Medical Officer

Peter Lamb

55 2016 Executive Vice President - Scientific Strategy, Chief Scientific Officer